Poseida Therapeutics's total assets for Q0 0 were $293.58M, a decrease of -1.71% from the previous quarter. PSTX total liabilities were $206.37M for the fiscal quarter, a -13.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.